Li et al. suggested that treatment of S17092 decreased the concentration of Ac-SDKP through blocking Tβ4-POP-Ac-SDKP axis and restored pulmonary fibrosis in mutational mice expressing inactivated N-terminal catalytic sites of ACE with the induction of BLEO [116]. The gene discussed is ASAH1; the disease is pulmonary fibrosis.